Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.
The $25 service, available to adults 18 and older in the Birmingham area, combines the expertise of UAB Medicine providers with the convenience of online access.
If successful, the PRESERVE-1 trial could be a significant clinical breakthrough in the treatment of the condition by prolonging pregnancy and improving outcomes.
Since December, 21 living donor kidney transplants that have taken place at UAB are connected as donors “pay it forward” for a recipient to keep the chain going, and more transplants are scheduled for July.
UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Neurologist David Geldmacher, M.D., is launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
An inside pitch and a slip off the bat deliver a potentially blinding blow -- and a message for vision safety.
CreakyJoints, an online arthritis support community, and UAB are working to gather information directly from patients through smartphones and tablets to find better ways to treat conditions such as rheumatoid arthritis.
A project by ophthalmologists at the University of Alabama at Birmingham will examine whether a partnership with community-based optometrists will improve detection and treatment of glaucoma, especially for high-risk populations.
The S-ICD, which sits just below the skin, leaves the heart and blood vessels untouched while providing the same protection as traditional ICDs.